{"nctId":"NCT02443805","briefTitle":"Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR","startDateStruct":{"date":"2015-09-29","type":"ACTUAL"},"conditions":["Rhinitis, Allergic, Perennial","House Dust Mite Allergy"],"count":1607,"armGroups":[{"label":"300 IR","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: 300 IR"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Placebo"]}],"interventions":[{"name":"300 IR","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Main Inclusion Criteria:\n\n* Patients with HDM-associated allergic rhinitis (AR) for at least 1 year\n* Patients sensitized to D. pteronyssinus (D. pte) and/or D. farinae (D. far) defined on skin prick test and HDM-specific serum IgE\n\nMain Exclusion Criteria:\n\n* A history of rhinitis, rhinoconjunctivitis or asthma to allergens other than HDM, likely to result in rhinitis symptoms during the evaluation periods\n* Partly controlled or uncontrolled asthma\n* Controlled asthma requiring controller treatment(s) consistent with GINA 2014 treatment Steps 3 to 5","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","maximumAge":"65 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Total Combined Score","description":"Average Total Combined Score (TCS), calculated for each patient as the average of the non-missing daily TCSs during the primary evaluation period. The daily TCS (scale 0-15) was the sum of the patient's daily Rhinitis Total Symptom Score (RTSS, scale 0-12) and daily Rescue Medication Score (RMS, scale 0-3). Lower is better.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.62","spread":null},{"groupId":"OG001","value":"4.35","spread":null}]}]}]},{"type":"SECONDARY","title":"Average Rhinitis Total Symptom Score (RTSS)","description":"Average RTSS during the primary evaluation period. The daily Total Symptom Scores (RTSS) was the sum of the 4 rhinitis symptom scores: sneezing, rhinorrhoea, nasal pruritus and nasal congestion, each graded on a 4-point scale (0-3; 0: absent, 1: mild, 2: moderate, 3: severe).\n\nIt ranges from 0 to 12. Lower is better.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.16","spread":null},{"groupId":"OG001","value":"3.79","spread":null}]}]}]},{"type":"SECONDARY","title":"Average Rescue Medication Score (RMS)","description":"Average RMS during the primary evaluation period. Rescue Medication Score (RMS) ; range 0-3, lower is better.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.21","spread":null},{"groupId":"OG001","value":"0.30","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":21,"n":800},"commonTop":["Nasopharyngitis","Oral pruritus","Throat irritation","Ear pruritus","Headache"]}}}